本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oncolytics Biotech Inc

0.5700
+0.01382.48%
盘后0.57000.00000.00%16:05 EDT
成交量:43.55万
成交额:24.75万
市值:4,936.25万
市盈率:-1.98
高:0.5867
开:0.5800
低:0.5556
收:0.5562
数据加载中...
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]